SHS Gesellschaft für Beteiligungsmanagement mbH

SHS News

7. October 2024 - SHS News

Healthcare Specialist SHS Capital, together with its Partners, invests further capital in Develco to meet exceptional market demand

Tuebingen / 07.10.2024 SHS Capital is pleased to announce a significant investment alongside its limited partners in one of its portfolio companies, Develco. SHS Capital has been a committed investor since 2020 and is pleased to have offered its LPs the opportunity to co-invest in Develco. Develco is a specialty pharma company focused on the […]

Read more
13. September 2023 - SHS News

Healthcare Specialist SHS Capital announces Final Closing of its oversubscribed Sixth Fund Generation totaling EUR 270 million

The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size The new fund will invest in European growing healthcare companies and allocates […]

Read more
10. August 2023 - SHS News

Healthcare specialist SHS Capital acquires Majority Stake in Life Science Robotics Company ESSERT

SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors The company’s core product is the ESSERT MicroFactory, a modular production platform for the automation of low-volume, high-mix […]

Read more
7. July 2023 - SHS News

Healthcare Specialist SHS Capital acquires majority stake in CAM Bioceramics to support and accelerate its future growth

CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders This investment is the third transaction […]

Read more
27. June 2023 - SHS News

Healthcare specialist SHS Capital sells Spiegelberg, a leading medtech expert for devices and consumables in the field of neurosurgery, to Luciole Medical

Spiegelberg GmbH & Co. KG is one of the leading suppliers in the field of manufacturing devices and consumables for intracranial pressure measurement and has been able to grow strongly in recent years  Luciole Medical AG, which specialises in cerebral monitoring and measurement of oxygen saturation in the brain, is expanding its product range with […]

Read more
22. June 2023 - SHS News

Healthcare specialist SHS Capital Invests €18 Mio in MESI Medical to Bring Digital Diagnostics to the Core of Healthcare Services

SHS partners with the founders of MESI, a fast-growing Slovenia-based diagnostic company growing revenues >50% p.a. in the last 5 years MESI’s cutting-edge technology digitalizes medical assessment, resulting in workflow optimisation, cost saving and improved patient outcomes The investment aims to further accelerate MESI’s growth and global market presence, and help to transform healthcare with […]

Read more
2. March 2023 - Portfolio News, SHS News

More patient safety with simulators for cardiologists – SHS invests 10 million euro in Swiss Simulands AG

SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]

Read more
20. December 2022 - SHS News

Cautious growth: SHS Medical Technology Index grows slightly in second year of Corona crisis

Medical technology market in Germany with slight growth in 2021 Pandemic leaves positive as well as negative traces on medical technology companies in second year, with the former predominating SHS expects a good development for medical technology in Germany in 2022 due to the improvement in the pandemic situation The new regulatory requirements (MDR/IVDR) will […]

Read more
18. July 2022 - SHS News

More than 220 million euros for growth and succession investments in European healthcare companies. SHS launches sixth fund generation and exceeds target volume already in first closing

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]

Read more
1
234Next